Balance Sheet ResMed, Inc.

Equities

RMD

US7611521078

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 02:30:02 06/12/2025 am IST			5-day change	1st Jan Change
256.55 ^USD	+2.00%		+0.28%	+12.18%

05/12	Resmed Insider Sold Shares Worth $502,940, According to a Recent SEC Filing	MT
02/12	LivaNova PLC Appoints Lucile Blaise as Global Head of Commercialization, Obstructive Sleep Apnea, Effective December 1, 2025	CI

e.4IliLt7nImUEQIjF6lAcgeFYUYHYJYX3MuWTnleDKCE.id8aZ-uQSxFAEMW_pBMs6IQPMtCib927QbfRqCfvbknU_yMcqKx1PXcK6w

Published financial data: RESMED, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: June	2021	2022	2023	2024	2025
Revenues	319.68Cr	357.81Cr	422.3Cr	468.53Cr	514.63Cr
Total Revenues	319.68Cr	357.81Cr	422.3Cr	468.53Cr	514.63Cr
Cost of Goods Sold, Total	130.74Cr	151.42Cr	183.69Cr	199.7Cr	205.92Cr
Gross Profit	188.95Cr	206.4Cr	238.61Cr	268.83Cr	308.71Cr
Selling General & Admin Expenses, Total	67Cr	74Cr	87Cr	92Cr	99Cr
R&D Expenses	23Cr	25Cr	29Cr	31Cr	33Cr
Amortization of Goodwill and Intangible Assets - (IS)	7.62Cr	7.07Cr	7.24Cr	7.95Cr	7.74Cr
Other Operating Expenses, Total	97Cr	106.37Cr	123.41Cr	130.41Cr	139.97Cr
Operating Income	92Cr	100.03Cr	115.2Cr	138.41Cr	168.74Cr
Interest Expense, Total	-2.4Cr	-2.23Cr	-4.74Cr	-4.97Cr	-6L
Interest And Investment Income	4L	-	-	-	-
Net Interest Expenses	-2.36Cr	-2.23Cr	-4.74Cr	-4.97Cr	-6L
Income (Loss) On Equity Invest.	-1.12Cr	-84.86L	-72.65L	-18.48L	36.44L
Currency Exchange Gains (Loss)	-8L	-	-42.04L	-1L	-23.9L
Other Non Operating Income (Expenses)	10.54L	31.97L	-15.08L	7L	18.33L
EBT, Excl. Unusual Items	88Cr	97Cr	109.16Cr	133.31Cr	168.99Cr
Restructuring Charges	-1.39Cr	-	-91.77L	-6.42Cr	-
Merger & Related Restructuring Charges	-	-	-1.09Cr	-	-20.31L
Gain (Loss) On Sale Of Investments	1.45Cr	-1.22Cr	99.22L	-40.45L	-1.03Cr
Insurance Settlements	-	-	2.02Cr	-	-
Legal Settlements	-	-	-	-	-
EBT, Incl. Unusual Items	88Cr	96Cr	110.17Cr	126.48Cr	167.76Cr
Income Tax Expense	41Cr	18Cr	20Cr	24Cr	28Cr
Earnings From Continuing Operations	47Cr	78Cr	90Cr	102.1Cr	140.07Cr
Net Income to Company	47Cr	78Cr	90Cr	102.1Cr	140.07Cr
Net Income - (IS)	47Cr	78Cr	90Cr	102.1Cr	140.07Cr
Net Income to Common Incl Extra Items	47Cr	78Cr	90Cr	102.1Cr	140.07Cr
Net Income to Common Excl. Extra Items	47Cr	78Cr	90Cr	102.1Cr	140.07Cr
Per Share Items
Net EPS - Basic	3.27	5.34	6.12	6.94	9.55
Basic EPS - Continuing Operations	3.27	5.34	6.12	6.94	9.55
Basic Weighted Average Shares Outstanding	15Cr	15Cr	15Cr	15Cr	15Cr
Net EPS - Diluted	3.24	5.3	6.09	6.92	9.51
Diluted EPS - Continuing Operations	3.24	5.3	6.09	6.92	9.51
Diluted Weighted Average Shares Outstanding	15Cr	15Cr	15Cr	15Cr	15Cr
Normalized Basic EPS	3.8	4.16	4.65	5.67	7.2
Normalized Diluted EPS	3.77	4.13	4.63	5.65	7.17
Dividend Per Share	1.59	1.68	1.76	1.92	2.12
Payout Ratio	47.78	31.48	28.78	27.65	22.19
American Depositary Receipts Ratio (ADR)	0.25	0.25	0.25	0.25	0.25
Supplemental Items
EBITDA	102.9Cr	112.44Cr	129.21Cr	153.35Cr	186.04Cr
EBITA	95Cr	103.55Cr	119.94Cr	143.62Cr	173.93Cr
EBIT	92Cr	100.03Cr	115.2Cr	138.41Cr	168.74Cr
EBITDAR	106.45Cr	115.96Cr	132.57Cr	157.43Cr	189.94Cr
Total Revenues (As Reported)	319.68Cr	357.81Cr	422.3Cr	468.53Cr	514.63Cr
Effective Tax Rate - (Ratio)	46.3	18.85	18.53	19.28	16.5
Current Domestic Taxes	-11Cr	1.51Cr	5.08Cr	7.44Cr	3.97Cr
Current Foreign Taxes	53Cr	18Cr	20Cr	22Cr	30Cr
Total Current Taxes	43Cr	19Cr	25Cr	29Cr	34Cr
Deferred Domestic Taxes	-2.7Cr	-1.54Cr	-2.41Cr	-2.75Cr	-69.32L
Deferred Foreign Taxes	1.04Cr	35.67L	-2.13Cr	-2.23Cr	-5.41Cr
Total Deferred Taxes	-1.66Cr	-1.18Cr	-4.54Cr	-4.99Cr	-6.1Cr
Normalized Net Income	55Cr	61Cr	68Cr	83Cr	105.62Cr
Interest on Long-Term Debt	2.4Cr	-	4.74Cr	-	-
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	23Cr	25Cr	29Cr	31Cr	33Cr
Net Rental Expense, Total	3.55Cr	3.53Cr	3.36Cr	4.08Cr	3.9Cr
Imputed Operating Lease Interest Expense	65.1L	73.64L	1.02Cr	1.32Cr	2L
Imputed Operating Lease Depreciation	2.9Cr	2.79Cr	2.34Cr	2.76Cr	3.88Cr
Stock-Based Comp., COGS (Total)	41.53L	52.18L	64.65L	75.63L	89.45L
Stock-Based Comp., R&D Exp. (Total)	80.47L	92.48L	1.16Cr	1.45Cr	1.81Cr
Stock-Based Comp., SG&A Exp. (Total)	5.17Cr	5.08Cr	5.3Cr	5.81Cr	6.46Cr
Total Stock-Based Compensation	6.39Cr	6.53Cr	7.11Cr	8.02Cr	9.17Cr

Fiscal Period: June	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	30Cr	27Cr	23Cr	24Cr	120.94Cr
Short Term Investments	2.91Cr	-	1.24Cr	-	-
Total Cash And Short Term Investments	32Cr	27Cr	24Cr	24Cr	120.94Cr
Accounts Receivable, Total	63Cr	60Cr	74Cr	84Cr	99Cr
Total Receivables	63Cr	60Cr	74Cr	84Cr	99Cr
Inventory	46Cr	85Cr	114.11Cr	99Cr	98Cr
Prepaid Expenses	9.58Cr	20Cr	25Cr	29Cr	33Cr
Other Current Assets, Total	7.24Cr	-	21.26L	-	-
Total Current Assets	157.48Cr	193.15Cr	236.78Cr	235.77Cr	350.56Cr
Gross Property Plant And Equipment	121.42Cr	126.36Cr	133.38Cr	142.61Cr	142.36Cr
Accumulated Depreciation	-62Cr	-63Cr	-67Cr	-73Cr	-71Cr
Net Property Plant And Equipment	59Cr	63Cr	67Cr	70Cr	72Cr
Long-term Investments	4.02Cr	4.92Cr	13Cr	14Cr	14Cr
Goodwill	192.79Cr	193.64Cr	277.03Cr	284.21Cr	304.67Cr
Other Intangibles, Total	39Cr	35Cr	55Cr	49Cr	46Cr
Accounts Receivable Long-Term	62.14L	88.4L	1.01Cr	1.84Cr	1.46Cr
Deferred Tax Assets Long-Term	7.99Cr	7.97Cr	13Cr	20Cr	25Cr
Other Long-Term Assets, Total	11Cr	11Cr	12Cr	13Cr	3.14Cr
Total Assets	472.81Cr	509.59Cr	675.17Cr	687.24Cr	817.44Cr
Liabilities
Accounts Payable, Total	14Cr	16Cr	15Cr	24Cr	28Cr
Accrued Expenses, Total	29Cr	32Cr	33Cr	34Cr	36Cr
Short-term Borrowings	-	-	-	-	-
Current Portion of Long-Term Debt	1.2Cr	99.16L	99.02L	99L	99L
Current Portion of Leases	2.36Cr	2.19Cr	2.19Cr	2.53Cr	3.05Cr
Current Income Taxes Payable	31Cr	4.49Cr	7.22Cr	11Cr	13Cr
Unearned Revenue Current, Total	11Cr	11Cr	14Cr	15Cr	17Cr
Other Current Liabilities	3.02Cr	2.59Cr	3.72Cr	3.98Cr	3.99Cr
Total Current Liabilities	91Cr	69Cr	76Cr	91Cr	101.91Cr
Long-Term Debt	64Cr	77Cr	143.12Cr	70Cr	66Cr
Long-Term Leases	11Cr	12Cr	12Cr	14Cr	15Cr
Unearned Revenue Non Current	9.15Cr	9.55Cr	12Cr	14Cr	16Cr
Deferred Tax Liability Non Current	1.13Cr	97.14L	9.06Cr	7.93Cr	7.77Cr
Other Non Current Liabilities	6.97Cr	5.49Cr	11Cr	4.23Cr	14Cr
Total Liabilities	184.24Cr	173.51Cr	262.18Cr	200.84Cr	220.65Cr
Common Stock, Total	6L	6L	6L	6L	8L
Additional Paid In Capital	162.22Cr	168.24Cr	177.21Cr	189.66Cr	203.36Cr
Retained Earnings	307.96Cr	361.37Cr	425.3Cr	499.16Cr	608.15Cr
Treasury Stock	-162.33Cr	-162.33Cr	-162.33Cr	-177.33Cr	-207.33Cr
Comprehensive Income and Other	-19Cr	-31Cr	-27Cr	-25Cr	-7.47Cr
Total Common Equity	288.57Cr	336.08Cr	412.99Cr	486.4Cr	596.79Cr
Total Equity	288.57Cr	336.08Cr	412.99Cr	486.4Cr	596.79Cr
Total Liabilities And Equity	472.81Cr	509.59Cr	675.17Cr	687.24Cr	817.44Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	15Cr	15Cr	15Cr	15Cr	15Cr
ECS Total Common Shares Outstanding	15Cr	15Cr	15Cr	15Cr	15Cr
Book Value / Share	19.81	22.95	28.08	33.11	40.77
Tangible Book Value	57Cr	107.84Cr	81Cr	153.61Cr	245.63Cr
Tangible Book Value Per Share	3.88	7.37	5.49	10.46	16.78
Total Debt	79Cr	92Cr	157.99Cr	87Cr	85Cr
Net Debt	47Cr	64Cr	133.96Cr	64Cr	-36Cr
Debt Equivalent Oper. Leases	28Cr	28Cr	27Cr	33Cr	31Cr
Equity Method Investments, Total	1.72Cr	99.18L	6.54Cr	6.55Cr	7.62Cr
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	16Cr	36Cr	46Cr	36Cr	37Cr
Inventories - Work In Process, Total	46.47L	30.77L	39.56L	27.13L	25.5L
Inventories - Finished Goods, Total	30Cr	39Cr	53Cr	46Cr	56Cr
Land - (BS)	5.45Cr	5.19Cr	5.21Cr	5.2Cr	5.17Cr
Buildings, Total	24Cr	23Cr	23Cr	23Cr	23Cr
Machinery, Total	71Cr	77Cr	83Cr	89Cr	85Cr
Full Time Employees	7.97T	8.16T	10.14T	9.98T	10.6T
Accumulated Allowance for Doubtful Accounts (Supple)	3.21Cr	2.33Cr	2.36Cr	2.11Cr	2.24Cr

Fiscal Period: June	2021	2022	2023	2024	2025
Net Income	47Cr	78Cr	90Cr	102.1Cr	140.07Cr
Depreciation & Amortization - CF	12Cr	12Cr	13Cr	14Cr	16Cr
Amortization of Goodwill and Intangible Assets - (CF)	3.09Cr	3.52Cr	4.74Cr	5.2Cr	5.19Cr
Depreciation & Amortization, Total	15Cr	16Cr	17Cr	19Cr	21Cr
Amortization of Deferred Charges, Total - (CF)	4.02Cr	3.55Cr	2.51Cr	2.74Cr	2.55Cr
(Gain) Loss on Sale of Investments - (CF)	-1.45Cr	1.22Cr	-99.22L	40.45L	1.03Cr
Asset Writedown & Restructuring Costs	1.38Cr	-	91.77L	3.32Cr	-
(Income) Loss On Equity Investments - (CF)	1.12Cr	84.86L	1.01Cr	18.48L	-36.44L
Stock-Based Compensation (CF)	6.39Cr	6.53Cr	7.11Cr	8.02Cr	9.17Cr
Other Operating Activities, Total	-	-	-2.02Cr	-	-
Change In Accounts Receivable	-13Cr	1.93Cr	-11Cr	-13Cr	-7.67Cr
Change In Inventories	-2.2Cr	-31Cr	-25Cr	17Cr	-8.02Cr
Change In Accounts Payable	21Cr	-25Cr	3.13Cr	12Cr	9.1Cr
Change in Other Net Operating Assets	-5.82Cr	-17Cr	-14Cr	-12Cr	8.26Cr
Cash from Operations	74Cr	35Cr	69Cr	140.13Cr	175.16Cr
Capital Expenditure	-10Cr	-13Cr	-12Cr	-9.95Cr	-8.99Cr
Cash Acquisitions	-3.91Cr	-4.28Cr	-101.27Cr	-13Cr	-14Cr
Sale (Purchase) of Intangible assets	-1.41Cr	-2.12Cr	-1.43Cr	-1.54Cr	-1.08Cr
Investment in Marketable and Equity Securities, Total	-2.18Cr	-1.39Cr	-2.83Cr	-1.18Cr	-17.88L
Other Investing Activities, Total	1.92Cr	-1.72Cr	1.52Cr	-96.99L	4.16Cr
Cash from Investing	-16Cr	-23Cr	-115.98Cr	-27Cr	-20Cr
Long-Term Debt Issued, Total	9Cr	29Cr	107Cr	10Cr	-
Total Debt Issued	9Cr	29Cr	107Cr	10Cr	-
Long-Term Debt Repaid, Total	-61Cr	-17Cr	-40Cr	-84Cr	-4Cr
Total Debt Repaid	-61Cr	-17Cr	-40Cr	-84Cr	-4Cr
Issuance of Common Stock	3.78Cr	4.74Cr	4.91Cr	5.31Cr	7.44Cr
Repurchase of Common Stock	-5.02Cr	-5.24Cr	-3.06Cr	-16Cr	-32Cr
Common Dividends Paid	-23Cr	-25Cr	-26Cr	-28Cr	-31Cr
Common & Preferred Stock Dividends Paid	-23Cr	-25Cr	-26Cr	-28Cr	-31Cr
Other Financing Activities, Total	-35L	-	-23.61L	-12.93L	-1.17Cr
Cash from Financing	-76Cr	-13Cr	42Cr	-111.93Cr	-61Cr
Foreign Exchange Rate Adjustments	1.85Cr	-1.44Cr	-21.47L	-17.19L	2.58Cr
Net Change in Cash	-17Cr	-2.16Cr	-4.58Cr	1.05Cr	97Cr
Supplemental Items
Cash Interest Paid	2.4Cr	2.23Cr	4.74Cr	4.57Cr	2.84Cr
Cash Income Tax Paid (Refund)	22Cr	48Cr	22Cr	28Cr	21Cr
Levered Free Cash Flow	81Cr	12Cr	42Cr	118.49Cr	120.75Cr
Unlevered Free Cash Flow	82Cr	13Cr	44Cr	121.6Cr	120.79Cr
Change In Net Working Capital	-12Cr	60Cr	41Cr	-17Cr	7.36Cr
Net Debt Issued / Repaid	-52Cr	12Cr	66Cr	-73Cr	-4Cr

Fiscal Period: June	2021	2022	2023	2024	2025
Profitability
Return on Assets	12.31	12.73	12.15	12.7	14.02
Return on Total Capital	15.34	15.71	14.42	15.11	16.8
Return On Equity %	17.63	24.96	23.96	22.7	25.86
Return on Common Equity	17.63	24.96	23.96	22.7	25.86
Margin Analysis
Gross Profit Margin %	59.1	57.68	56.5	57.38	59.99
SG&A Margin	20.97	20.66	20.7	19.57	19.26
EBITDA Margin %	32.19	31.42	30.6	32.73	36.15
EBITA Margin %	29.67	28.94	28.4	30.65	33.8
EBIT Margin %	28.7	27.96	27.28	29.54	32.79
Income From Continuing Operations Margin %	14.84	21.78	21.25	21.79	27.22
Net Income Margin %	14.84	21.78	21.25	21.79	27.22
Net Avail. For Common Margin %	14.84	21.78	21.25	21.79	27.22
Normalized Net Income Margin	17.26	16.99	16.16	17.78	20.52
Levered Free Cash Flow Margin	25.29	3.28	9.84	25.29	23.46
Unlevered Free Cash Flow Margin	25.76	3.67	10.54	25.95	23.47
Asset Turnover
Asset Turnover	0.69	0.73	0.71	0.69	0.68
Fixed Assets Turnover	5.67	5.85	6.52	6.87	7.26
Receivables Turnover (Average Receivables)	5.76	5.83	6.31	6.08	5.52
Inventory Turnover (Average Inventory)	2.99	2.3	1.84	1.87	2.09
Short Term Liquidity
Current Ratio	1.73	2.8	3.12	2.59	3.44
Quick Ratio	1.04	1.27	1.29	1.18	2.16
Operating Cash Flow to Current Liabilities	0.81	0.51	0.91	1.54	1.72
Days Sales Outstanding (Average Receivables)	63.33	62.57	57.83	60.23	66.18
Days Outstanding Inventory (Average Inventory)	122	158.52	197.94	195.69	174.63
Average Days Payable Outstanding	37.08	28.53	26.6	38.42	46.13
Cash Conversion Cycle (Average Days)	148.24	192.56	229.16	217.51	194.67
Long Term Solvency
Total Debt/Equity	27.51	27.3	38.26	17.97	14.27
Total Debt / Total Capital	21.57	21.45	27.67	15.23	12.49
LT Debt/Equity	26.27	26.36	37.48	17.24	13.6
Long-Term Debt / Total Capital	20.6	20.7	27.11	14.62	11.9
Total Liabilities / Total Assets	38.97	34.05	38.83	29.22	26.99
EBIT / Interest Expense	38.25	44.83	24.31	27.84	2.88T
EBITDA / Interest Expense	44.37	51.97	27.98	31.67	3.25T
(EBITDA - Capex) / Interest Expense	40.09	45.93	25.45	29.66	3.09T
Total Debt / EBITDA	0.75	0.79	1.19	0.56	0.45
Net Debt / EBITDA	0.44	0.56	1.01	0.4	-0.19
Total Debt / (EBITDA - Capex)	0.83	0.9	1.31	0.59	0.47
Net Debt / (EBITDA - Capex)	0.49	0.63	1.11	0.43	-0.2
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	8.11	11.93	18.02	10.95	9.84
Gross Profit, 1 Yr. Growth %	6.91	9.24	15.61	12.67	14.84
EBITDA, 1 Yr. Growth %	11.5	9.27	14.73	18.69	21.31
EBITA, 1 Yr. Growth %	11.88	9.17	15.62	19.74	21.11
EBIT, 1 Yr. Growth %	13.41	9.01	14.95	20.15	21.91
Earnings From Cont. Operations, 1 Yr. Growth %	-23.67	64.26	15.15	13.75	37.2
Net Income, 1 Yr. Growth %	-23.67	64.26	15.15	13.75	37.2
Normalized Net Income, 1 Yr. Growth %	18.21	10.15	12.01	22.12	26.77
Diluted EPS Before Extra, 1 Yr. Growth %	-24.12	63.58	14.91	13.63	37.43
Accounts Receivable, 1 Yr. Growth %	29.15	-3.77	22.4	18.78	13.16
Inventory, 1 Yr. Growth %	9.62	83.45	34.06	-12.85	-1.86
Net Property, Plant and Equip., 1 Yr. Growth %	10.53	6.49	5.6	5.01	2.74
Total Assets, 1 Yr. Growth %	3.07	7.78	32.49	1.79	18.95
Tangible Book Value, 1 Yr. Growth %	256.51	90.79	-25.14	90.28	59.91
Common Equity, 1 Yr. Growth %	15.56	16.46	22.89	17.78	22.69
Cash From Operations, 1 Yr. Growth %	-8.17	-52.34	97.44	102.11	25
Capital Expenditures, 1 Yr. Growth %	7.74	31.27	-11.25	-16.89	-9.65
Levered Free Cash Flow, 1 Yr. Growth %	40.17	-84.95	225.3	195.78	1.91
Unlevered Free Cash Flow, 1 Yr. Growth %	36.78	-83.47	214.18	181.11	-0.66
Dividend Per Share, 1 Yr. Growth %	1.92	5.66	4.76	9.09	10.42
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	10.75	10	14.93	14.43	10.39
Gross Profit, 2 Yr. CAGR %	10.89	8.06	12.38	14.13	13.75
EBITDA, 2 Yr. CAGR %	16.91	10.38	12.06	16.69	19.99
EBITA, 2 Yr. CAGR %	18.36	10.52	12.45	17.66	20.42
EBIT, 2 Yr. CAGR %	20.12	11.19	12.05	17.52	21.03
Earnings From Cont. Operations, 2 Yr. CAGR %	8.3	11.97	37.53	14.45	24.92
Net Income, 2 Yr. CAGR %	8.3	11.97	37.53	14.45	24.92
Normalized Net Income, 2 Yr. CAGR %	22.28	14.11	11.19	16.96	24.42
Diluted EPS Before Extra, 2 Yr. CAGR %	7.57	11.41	37.1	14.27	24.96
Accounts Receivable, 2 Yr. CAGR %	7.77	11.48	8.53	17.97	18.55
Inventory, 2 Yr. CAGR %	14.33	42.89	56.82	8.09	-7.52
Net Property, Plant and Equip., 2 Yr. CAGR %	23.62	8.49	6.05	5.3	3.87
Total Assets, 2 Yr. CAGR %	7.29	5.4	19.5	16.13	10.03
Tangible Book Value, 2 Yr. CAGR %	35.86	160.81	19.51	19.35	74.44
Common Equity, 2 Yr. CAGR %	18.01	16.01	19.63	20.3	20.21
Cash From Operations, 2 Yr. CAGR %	26.68	-33.84	-2.99	99.76	58.95
Capital Expenditures, 2 Yr. CAGR %	22.26	18.93	7.94	-14.11	-13.34
Levered Free Cash Flow, 2 Yr. CAGR %	38.19	-54.92	-27.01	204.63	73.62
Unlevered Free Cash Flow, 2 Yr. CAGR %	35.89	-53.3	-25.16	193.01	67.11
Dividend Per Share, 2 Yr. CAGR %	2.96	3.77	5.21	6.9	9.75
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	10.96	11.14	12.61	13.59	12.88
Gross Profit, 3 Yr. CAGR %	11.52	10.34	10.52	12.47	14.36
EBITDA, 3 Yr. CAGR %	15.95	14.3	11.87	14.23	18.21
EBITA, 3 Yr. CAGR %	17.37	15.22	12.26	14.83	18.8
EBIT, 3 Yr. CAGR %	17.87	16.29	12.5	14.69	18.97
Earnings From Cont. Operations, 3 Yr. CAGR %	14.56	24.43	13.02	29.1	21.58
Net Income, 3 Yr. CAGR %	14.56	24.43	13.02	29.1	21.58
Normalized Net Income, 3 Yr. CAGR %	17	18.1	13.48	14.72	20.14
Diluted EPS Before Extra, 3 Yr. CAGR %	13.95	23.7	12.56	28.78	21.52
Accounts Receivable, 3 Yr. CAGR %	7.95	3.78	15.01	10.23	18.09
Inventory, 3 Yr. CAGR %	19.37	34.53	39.88	28.93	4.66
Net Property, Plant and Equip., 3 Yr. CAGR %	15.27	17.62	7.52	5.7	4.44
Total Assets, 3 Yr. CAGR %	15.56	7.45	13.75	13.28	17.06
Tangible Book Value, 3 Yr. CAGR %	-9.98	52.14	72.04	39.55	31.57
Common Equity, 3 Yr. CAGR %	11.91	17.49	18.26	19.01	21.1
Cash From Operations, 3 Yr. CAGR %	13.41	-8.54	-4.75	23.9	70.86
Capital Expenditures, 3 Yr. CAGR %	17.96	25.2	7.88	-1.07	-12.65
Levered Free Cash Flow, 3 Yr. CAGR %	16.3	-34.8	-10.4	14.97	111.47
Unlevered Free Cash Flow, 3 Yr. CAGR %	15.7	-33.48	-9.59	15.24	104.31
Dividend Per Share, 3 Yr. CAGR %	3.84	3.85	4.1	6.49	8.06
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	11.7	11.6	12.53	12.44	11.72
Gross Profit, 5 Yr. CAGR %	12.12	11.42	11.86	11.84	11.8
EBITDA, 5 Yr. CAGR %	14.51	14.6	14.37	15.29	15.05
EBITA, 5 Yr. CAGR %	15.58	15.52	15.38	16.23	15.46
EBIT, 5 Yr. CAGR %	16.05	16.97	15.51	16.83	15.84
Earnings From Cont. Operations, 5 Yr. CAGR %	6.13	17.89	23.25	20.34	17.64
Net Income, 5 Yr. CAGR %	6.13	17.89	23.25	20.34	17.64
Normalized Net Income, 5 Yr. CAGR %	14.58	16.58	14.64	17.68	17.74
Diluted EPS Before Extra, 5 Yr. CAGR %	5.41	17.17	22.7	19.84	17.37
Accounts Receivable, 5 Yr. CAGR %	10.35	5.96	8.18	9.24	15.4
Inventory, 5 Yr. CAGR %	15.28	25.97	33.54	23.25	18.54
Net Property, Plant and Equip., 5 Yr. CAGR %	9.03	9.85	11.49	12.53	6.04
Total Assets, 5 Yr. CAGR %	7.74	8	17.12	10.84	12.25
Tangible Book Value, 5 Yr. CAGR %	10.98	11.22	0.82	38.06	72.99
Common Equity, 5 Yr. CAGR %	11.23	11.38	14.94	18.61	19.04
Cash From Operations, 5 Yr. CAGR %	6.1	-3.24	6.54	25.01	16.9
Capital Expenditures, 5 Yr. CAGR %	11.9	16.73	13.84	7.68	-1.17
Levered Free Cash Flow, 5 Yr. CAGR %	14.82	-13.49	-4.17	22.85	15.9
Unlevered Free Cash Flow, 5 Yr. CAGR %	14.84	-12.76	-3.5	22.21	14.94
Dividend Per Share, 5 Yr. CAGR %	5.27	4.63	4.39	5.06	6.33